Left ventricular assist device performance with long-term circulatory support: Lessons from the REMATCH trial

Annals of Thoracic Surgery

Volumn 78, Issue 6, 2004, Pages 2123-2130

  Dembitsky, Walter P ^a   Tector, Alfred J ^c   Park, Soon ^a,d   Moskowitz, Alan J ^e   Gelijns, Annetine C ^e,k   Ronan, Nuala S ^e   Piccione Jr , William ^f   Holman, William L ^g   Furukawa, Satoshi ^h   Weinberg, Alan D ^e   Heatley, Gerald ⁱ   Poirier, Victor L ^a,i   Damme, Laura ⁱ   Long, James W ^j  

^a

^b

^c SHARP MEMORIAL HOSPITAL   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e Intl Ctr Hlth Outcomes/Innov R   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h TEMPLE UNIVERSITY HOSPITAL   (United States)

ⁱ THORATEC CORPORATION   (United States)

^j LDS HOSPITAL   (United States)

^k Och Spine at New York Presbyterian Hospitals   (United States)

more..

Author keywords

27

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PERFORMANCE; POISSON DISTRIBUTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POISSON DISTRIBUTION; PROSTHESIS FAILURE; SEPSIS; SURVIVAL RATE;

EID: 9344238774     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.02.030     Document Type: Article

References (8)

1. Rose E., Gelijns A., Moskowitz A., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 345:2001;1435-1443
2. Rose E.A., Moskowitz A.J., Packer M., et al. The REMATCH trial. rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg. 67:1999;723-730
3. Rector T., Cohn J. Pimobendan Multicenter Research Group. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire reliability and validity during a randomized, double-blind, controlled trial of pimobendan. Am Heart J. 124:1992;1017-1025
4. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-480
5. Geert V., Geert M. Linear mixed models for longitudinal data. 2000;Springer-Verlag, New York
6. Lazar RM, Shapiro PA, Jaski BE, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 2004;109:2423-7.
7. Holman WL, Park S, Long JW, et al. Infection in permanent circulatory support. Experience from the REMATCH Trial. J Heart Lung Transplant (in press, 2004)
8. Oz M.C., Gelijns A.C., Miller L., et al. Left ventricular assist devices as permanent heart failure therapy. The price of progress. Ann Surg. 238:2003;577-585